Complete Funding Blueprint
Recommended hereGet the complete self-serve report, roadmap, and multi-year stacking simulation.
$79USD · one time
View complete bundle Side-by-Side ComparisonGrant vs Grant
NSF SBIR vs. NIH SBIR: U.S. Federal Innovation Grants Compared
Understand the eligibility guidelines, funding caps, application timelines, and stacking playbooks for both options.
Research review: AshwaniVerified
FSI Digital Funding Research • Reviewed June 9, 2026Option A
NSF SBIR/STTR Startup Grants
Provides non-dilutive funding to early-stage startups developing highly innovative, high-risk technologies with deep commercial market potential.
View GuideOption B
NIH SBIR/STTR Biotech Grants
Known as America's Seed Fund for life sciences, these awards fund early-stage research and development with commercialization potential in biotech, medical devices, and digital health.
View GuideHead-to-Head Criteria Comparison
| Dimension | NSF Parameters | NIH Parameters |
|---|---|---|
| Primary Focus | Broad deep-tech: software, AI, hardware, new materials, space tech | Life sciences: drug discovery, medical devices, diagnostics, digital health |
| Commercialization Model | High focus on market potential, private funding matching, commercial scale | Focus on scientific rigour, clinical efficacy, patient impact, NIH relevance |
| Phase I Amount | Up to $275,000 (usually 6–12 months duration) | Up to $275,000+ (usually 6–24 months duration) |
| First Contact | Mandatory 3-page "Project Pitch" portal review before full application | Optional contact with Program Officer; applications submitted on fixed cycles |
| University Partnership | Encouraged but optional; small business must lead the research | STTR option requires university/hospital partnership (min 30% project lead) |
Stacking Recommendation & Action Plan
How to optimize your filings by leveraging both programs in parallel.
Startups cannot stack NSF and NIH funding to cover the exact same technical research project (that is considered "duplicate funding" and is illegal). However, you can stack them across separate project areas:
- Complementary Projects: Use NIH SBIR to fund the medical validation and clinical testing of your health device, and use NSF SBIR to fund the core machine-learning model or computer vision pipeline that powers it.
- Phase Stacking: Startups frequently secure an NSF Phase I grant to prove general product feasibility, and then target NIH Phase II or separate clinical study allocations once patient impact criteria are defined.
Explore Stacking Options By Industry
Public funding eligibility varies significantly by sector. Select your industry to view custom program matches and stacking playbooks:
Related Programs
Detailed guides on programs related to this comparison:
NSF SBIR/STTR Startup Grants
Provides non-dilutive funding to early-stage startups developing highly innovative, high-risk technologies with deep commercial market potential.
NIH SBIR/STTR Biotech Grants
Known as America's Seed Fund for life sciences, these awards fund early-stage research and development with commercialization potential in biotech, medical devices, and digital health.
SR&ED Tax Credit
Canada's largest tax incentive for businesses conducting scientific research or experimental development. Provides a fully refundable investment tax credit (ITC) for eligible R&D expenditures.
IRAP Grant
Provides non-repayable grants and advisory support to help Canadian small and medium-sized enterprises (SMEs) develop and commercialize innovative technologies.
Unsure Which Path Yields the Most Funding?
Our analysts review business registration records, technical R&D payroll, and market goals to draft custom stacking models.
Step 1 of 5
Funding Eligibility Estimator
Calculate potential matching grants and tax credits for your business profile.
Related Programs
Local Funding Hubs
Browse city-level funding guides in this sector:
Official Program Alignment
FSI Digital reviews eligibility standards in accordance with official guidelines. We never guarantee funding; all approvals are subject to official government program review.